1857

COM:CKDPHARM

종근당

  • Stock

Last Close

101.60K

12/11 06:30

Market Cap

1.36T

Beta: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
73.20B
-
82.61B
12.86%
94.12B
13.94%
101.30B
7.63%
115.96B
14.48%
138.02B
19.02%
167.01B
21.00%
205.14B
22.83%
247.40B
20.60%
135.04B
45.42%
average payables
37.23B
-
44.79B
20.31%
60.37B
34.78%
71.19B
17.93%
69.89B
1.83%
85.28B
22.03%
123.04B
44.28%
136.72B
11.12%
137.38B
0.48%
72.72B
47.07%
average receivables
169.86B
-
178.69B
5.20%
202.15B
13.13%
217.84B
7.76%
216.85B
0.46%
211.19B
2.61%
216.27B
2.41%
230.83B
6.73%
261.01B
13.07%
143.65B
44.96%
book value per share
23.67K
-
26.30K
11.10%
24.95K
5.12%
28.11K
12.65%
30.36K
8.00%
34.21K
12.68%
37.79K
10.47%
44.04K
16.53%
45.54K
3.41%
5.93K
86.97%
capex per share
-168.24
-
-1.69K
905.70%
-2.83K
67.25%
-3.13K
10.59%
-1.61K
48.51%
-1.97K
22.02%
-1.98K
0.92%
-2.94K
48.19%
-4.17K
41.86%
-505.86
87.87%
capex to depreciation
-0.65
-
-1.04
60.67%
-1.57
51.58%
-1.65
4.75%
-0.97
41.15%
-1.16
19.74%
-1.08
7.13%
-1.55
43.52%
-1.89
21.87%
-1.58
16.28%
capex to operating cash flow
-0.21
-
-0.33
55.18%
-4.91
1,385.88%
-0.68
86.09%
-0.26
61.75%
-0.58
121.41%
-0.32
44.35%
-0.35
9.71%
-4.02
1,038.44%
-0.78
80.50%
capex to revenue
-0.02
-
-0.04
59.65%
-0.06
53.63%
-0.05
21.27%
-0.02
49.14%
-0.03
6.88%
-0.02
10.61%
-0.03
22.67%
-0.04
36.56%
-0.04
7.60%
cash per share
1.29K
-
4.07K
215.27%
1.02K
74.98%
1.72K
69.04%
3.44K
99.37%
3.67K
6.69%
7.37K
101.08%
12.93K
75.34%
15.07K
16.60%
1.49K
90.14%
days of inventory on hand
647.89
-
104.10
83.93%
110.84
6.47%
72.15
34.91%
72.58
0.60%
80.88
11.43%
80.27
0.75%
83.22
3.68%
96.76
16.26%
104.24
7.73%
days payables outstanding
313.29
-
55.42
82.31%
61.01
10.09%
52.28
14.31%
49.52
5.29%
43.48
12.19%
55.13
26.81%
64.63
17.23%
55.68
13.85%
56.13
0.81%
days sales outstanding
709.85
-
115.28
83.76%
114.29
0.85%
95.98
16.02%
89.53
6.72%
82.75
7.57%
69.52
15.98%
63.58
8.56%
63.76
0.29%
70.46
10.50%
debt to assets
0.24
-
0.22
9.03%
0.22
0.44%
0.19
10.19%
0.15
22.06%
0.15
2.95%
0.15
0.34%
0.14
2.35%
0.23
57.43%
0.21
7.47%
debt to equity
0.42
-
0.38
10.05%
0.40
5.37%
0.35
11.20%
0.26
27.47%
0.24
4.46%
0.25
2.32%
0.25
0.98%
0.42
69.64%
0.38
9.56%
dividend yield
0.00
-
0.01
81.16%
0.01
28.62%
0.01
2.69%
0.01
34.56%
0.01
2.57%
0.00
57.16%
0.01
128.10%
0.00
83.80%
earnings yield
0.01
-
0.06
730.64%
-0.01
113.09%
0.04
675.38%
0.04
10.04%
0.04
6.03%
0.05
24.80%
0.04
30.59%
0.03
8.72%
0.01
70.48%
enterprise value
752.34B
-
689.91B
8.30%
1.02T
47.22%
1.05T
3.64%
1.44T
37.21%
1.09T
24.56%
1.09T
0.13%
2.58T
136.92%
1.42T
45.10%
8.55T
502.62%
enterprise value over ebitda
73.59
-
9.28
87.38%
22.85
146.12%
12.00
47.47%
14.47
20.57%
11.62
19.70%
10.85
6.59%
17.18
58.31%
12.57
26.87%
59.05
369.97%
ev to operating cash flow
75.54
-
10.68
85.86%
139.67
1,207.64%
18.22
86.96%
17.68
2.92%
25.56
44.54%
14.12
44.77%
24.78
75.53%
109.98
343.86%
126.26
14.80%
ev to sales
8.72
-
1.27
85.45%
1.71
35.20%
1.27
26.19%
1.63
29.08%
1.14
30.23%
1.01
11.29%
1.98
96.25%
1.06
46.76%
5.75
444.00%
free cash flow per share
622.59
-
3.43K
451.42%
-2.25K
165.63%
1.46K
164.61%
4.56K
213.27%
1.44K
68.53%
4.18K
191.54%
5.39K
28.84%
-3.13K
158.11%
139.85
104.46%
free cash flow yield
0.01
-
0.07
475.91%
-0.03
144.59%
0.02
161.48%
0.04
125.20%
0.02
59.90%
0.05
186.24%
0.03
47.45%
-0.03
212.94%
0.00
105.87%
graham net net
-3.66K
-
-1.94K
46.96%
-5.14K
164.69%
-4.17K
18.86%
-1.03K
75.36%
-658.86
35.82%
-447.43
32.09%
2.41K
637.55%
-415.85
117.29%
26.58
106.39%
graham number
13.67K
-
40.63K
197.25%
17.37K
57.25%
45.33K
161.00%
52.70K
16.26%
51.03K
3.17%
60.47K
18.50%
85.15K
40.82%
59.34K
30.31%
10.15K
82.90%
income quality
2.25
-
1.84
18.52%
-1.07
158.44%
1.41
231.44%
1.52
7.71%
1.02
32.76%
1.46
42.74%
1.15
20.91%
0.30
73.60%
0.85
178.00%
intangibles to total assets
0.03
-
0.03
18.01%
0.03
1.86%
0.02
15.78%
0.02
8.59%
0.02
2.10%
0.02
8.10%
0.02
1.27%
0.02
1.17%
0.02
20.54%
0
100%
interest coverage
7.93
-
10.05
26.71%
9.81
2.36%
14.68
49.66%
22.16
50.89%
27.93
26.04%
23.67
15.24%
32.02
35.26%
23.51
26.56%
16.05
31.73%
interest debt per share
9.97K
-
10.31K
3.45%
10.23K
0.80%
10.22K
0.12%
8.01K
21.61%
8.55K
6.80%
9.67K
13.11%
11.18K
15.59%
19.40K
73.47%
2.31K
88.08%
inventory turnover
0.56
-
3.51
522.36%
3.29
6.08%
5.06
53.63%
5.03
0.60%
4.51
10.26%
4.55
0.76%
4.39
3.55%
3.77
13.99%
3.50
7.18%
invested capital
0.42
-
0.38
10.05%
0.40
5.37%
0.35
11.20%
0.26
27.47%
0.24
4.46%
0.25
2.32%
0.25
0.98%
0.42
69.64%
0.38
9.56%
market cap
640.93B
-
614.11B
4.18%
903.97B
47.20%
949.83B
5.07%
1.39T
46.07%
1.03T
25.68%
1.05T
1.83%
2.57T
145.02%
1.31T
48.92%
8.43T
541.88%
net current asset value
31.48B
-
56.13B
78.33%
26.64B
52.54%
51.31B
92.60%
92.99B
81.24%
109.74B
18.00%
144.74B
31.90%
205.37B
41.90%
186.26B
9.31%
210.02B
12.76%
net debt to ebitda
10.90
-
1.02
90.64%
2.51
146.40%
1.17
53.34%
0.57
51.31%
0.62
9.31%
0.41
34.43%
0.08
79.72%
0.93
1,023.00%
0.82
12.32%
net income per share
350.72
-
2.79K
695.32%
-537.28
119.26%
3.25K
704.72%
4.07K
25.15%
3.38K
16.80%
4.30K
27.11%
7.32K
70.18%
3.44K
53.03%
771.73
77.55%
operating cash flow per share
790.83
-
5.13K
548.06%
576.88
88.74%
4.59K
694.84%
6.17K
34.60%
3.40K
44.89%
6.17K
81.36%
8.33K
35.07%
1.04K
87.54%
645.71
37.80%
payables turnover
1.17
-
6.59
465.32%
5.98
9.17%
6.98
16.69%
7.37
5.59%
8.39
13.88%
6.62
21.14%
5.65
14.70%
6.55
16.08%
6.50
0.80%
receivables turnover
0.51
-
3.17
515.79%
3.19
0.86%
3.80
19.08%
4.08
7.21%
4.41
8.19%
5.25
19.03%
5.74
9.36%
5.72
0.29%
5.18
9.51%
research and ddevelopement to revenue
0.13
-
0.08
39.15%
0.10
23.73%
0.08
17.16%
0.07
8.91%
0.08
9.52%
0.09
13.42%
0.11
23.18%
0.12
7.97%
0.12
2.51%
return on tangible assets
0.01
-
0.06
619.44%
-0.01
119.17%
0.07
640.53%
0.08
24.27%
0.06
24.97%
0.07
12.63%
0.10
44.05%
0.04
57.86%
0.07
77.06%
0.15
106.57%
revenue per share
6.85K
-
43.18K
529.93%
47.00K
8.86%
66.02K
40.46%
66.83K
1.23%
76.30K
14.16%
86.14K
12.90%
104.06K
20.80%
108.10K
3.88%
14.19K
86.87%
roe
0.01
-
0.11
615.86%
-0.02
120.30%
0.12
636.84%
0.13
15.88%
0.10
26.17%
0.11
15.06%
0.17
46.04%
0.08
54.58%
0.13
72.33%
0.26
101.33%
roic
0.01
-
0.09
553.91%
-0.04
150.74%
0.09
311.98%
0.11
20.44%
0.09
21.97%
0.09
6.01%
0.13
44.46%
0.06
53.49%
0.11
70.39%
0.27
154.04%
sales general and administrative to revenue
0.06
-
0.04
27.02%
0.05
12.29%
0.03
26.73%
0.03
14.24%
0.03
6.89%
0.02
36.23%
0.01
32.37%
0.02
9.76%
0.02
0.66%
shareholders equity per share
23.67K
-
26.30K
11.10%
24.95K
5.12%
28.11K
12.65%
30.36K
8.00%
34.21K
12.68%
37.79K
10.47%
44.04K
16.53%
45.54K
3.41%
5.93K
86.97%
stock based compensation to revenue
tangible asset value
280.29B
-
315.37B
12.52%
298.72B
5.28%
339.39B
13.62%
388.96B
14.61%
415.52B
6.83%
459.04B
10.47%
532.56B
16.02%
545.00B
2.34%
594.34B
9.05%
1.40T
135.97%
tangible book value per share
22.26K
-
25.02K
12.44%
23.70K
5.30%
26.93K
13.64%
29.39K
9.15%
33.15K
12.80%
36.63K
10.50%
42.53K
16.09%
43.85K
3.10%
5.67K
87.08%
working capital
124.45B
-
137.12B
10.18%
136.92B
0.14%
127.32B
7.02%
142.86B
12.21%
185.82B
30.08%
194.07B
4.44%
279.49B
44.02%
346.92B
24.12%
339.40B
2.17%

All numbers in (except ratios and percentages)